New study explores what matters most to patients with high-risk head and neck skin cancer
NCT ID NCT05482880
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at how 78 patients with high-risk skin cancer on the head or neck felt about their treatment decisions, quality of life, and satisfaction with care. Researchers used standard questionnaires to measure these factors at two points: right after a team of doctors discussed the case, and one month after treatment ended. The goal was to better understand what patients experience during this complex care process.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Maastricht University Medical Center +
Maastricht, Limburg, Netherlands
-
Radboud UMC
Nijmegen, Gelderland, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tape to tame Post-Surgery face swelling?
- Can a virtual meadow or a Mind's eye stream calm hospital anxiety?
- Smartwatch could spot nerve damage before it starts
- Can diet and vitamin c supercharge rectal cancer treatment?
- Can healing at home beat hospital care for bedsores?
- Can Pre-Surgery immunotherapy prime the immune system to fight head and neck cancer?